Juneva Pharmaceuticals Private Limited
About Juneva Pharmaceuticals Private Limited
Data last updated:
Juneva Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 23 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U93000UP2013PTC061439. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shalini Singh Srivastava and Amit Srivastava.
Its last annual general meeting (AGM) was held on 28 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Flat No – 306 C – Block Goel Enclave Phase – IV Faizabad Road Chinhat, Lucknow, Uttar Pradesh, India – 227105.
As per the financials filed for FY 2021, the company reported a revenue of ₹5.58 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹2.85 Lakh (net margin -51.1%) and EBITDA of -₹2.83 Lakh (EBITDA margin -50.7%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 50% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Juneva Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No – 306 C – Block Goel Enclave Phase – IV Faizabad Road Chinhat, Lucknow, Uttar Pradesh, India – 227105
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Juneva Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Juneva Pharmaceuticals Private Limited
FY 2021 filings availableJuneva Pharmaceuticals Private Limited reported revenue of ₹5.58 Lakh (down 14% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 50%. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -50.7% | ||||
| Net Profit Margin | -51.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Juneva Pharmaceuticals Private Limited, buy the company report.
Board of directors of Juneva Pharmaceuticals Private Limited
Juneva Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalini Singh Srivastava | Director | 23 Dec 2013 | 12 Years 10 Months | Current |
| Amit Srivastava | Director | 31 Dec 2015 | 10 Years 10 Months | Current |
Auditor
Juneva Pharmaceuticals Private Limited is audited by VinodKumarYadav for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VinodKumarYadav | FY 2017 | 131473 |
Shareholding
The shareholding of Juneva Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Juneva Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Juneva Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Juneva Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Juneva Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Juneva Pharmaceuticals Private Limited, buy the company report.
Recent activity
Juneva Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Amit Srivastava was appointed as Director on 31 Dec 2015.
Frequently asked questions
Juneva Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in retail trading, within the trading industry. It was incorporated on 23 December 2013 (13+ years old) and is registered under CIN U93000UP2013PTC061439.
Juneva Pharmaceuticals has 2 current directors:
- Shalini Singh Srivastava - Director
- Amit Srivastava - Director
The latest financial statements of Juneva Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 28 November 2021. Year-wise statements from 2015 are in the company report.
No. Juneva Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Juneva Pharmaceuticals is U93000UP2013PTC061439. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Juneva Pharmaceuticals was incorporated on 23 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Amit Srivastava was appointed as Director on 31 Dec 2015. Shalini Kapoor ceased to be Director on 31 Dec 2015. Shalini Singh Srivastava was appointed as Director on 23 Dec 2013.
The registered office of Juneva Pharmaceuticals is at Flat No – 306 C – Block Goel Enclave Phase – IV Faizabad Road Chinhat, Lucknow, Uttar Pradesh, India – 227105.
Juneva Pharmaceuticals operates in the trading industry, in the retail trading segment.
The compliance status of Juneva Pharmaceuticals is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
